Ultramicrosize Griseofulvin - Griseofulvin 250 mg / 1 Tablet 30 Tablet

Reference details for licensed healthcare facility review and verification.

NDC 1162135-0495-30
Product NDC62135-0495
Generic Drug NameGriseofulvin
Brand NameUltramicrosize Griseofulvin
ManufacturerChartwell RX, LLC.
Strength250 mg / 1
Dosage FormTablet
Drug TypeOral
Package Quantity30 Tablet
Package Description30 TABLET in 1 BOTTLE, PLASTIC (62135-495-30)
Active IngredientsGriseofulvin
Marketing CategoryANDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

NDC snapshot

Griseofulvin 250 mg / 1 Tablet is tracked under NDC 62135-0495-30 and rolls up into product family 62135-0495. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

  • Package configuration: 30 Tablet.
  • Manufacturer: Chartwell RX, LLC..
  • Dosage form: Tablet.
  • Family size: 2 indexed presentations.

Click a tag to refine the catalog view around this product reference.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Alternate presentations in this family

These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.

Ultramicrosize Griseofulvin - Griseofulvin 250 mg / 1 Tablet 30 Tablet, NDC 62135-0495-30, is a Chartwell RX, LLC. 250 mg / 1 tablet presentation packaged as 30 Tablet.

NDC search formats

  • Canonical NDC 11: 62135-0495-30
  • Digits-only NDC 11: 62135049530
  • Possible 10-digit display format: 62135-495-30 (6213549530)

Helpful product links